The Global Ophthalmic Eye Drops Industry emerges as a beacon of growth, casting a radiant light on the expansive landscape of the healthcare industry. Propelled by its immense potential, the market is set to achieve a remarkable valuation of US$ 16.21 billion in 2023, according to the latest insights from Future Mar.
The project is part of the Bormioli Pharma Invents innovation program, which aims to provide concrete answers to some of the most important challenges in the pharmaceutical packaging sector
Primarily fueled by biopharmaceutical and pharmaceutical demand, the global sales of pharmaceutical glass ampoules will witness a staggering rise between.